Developer of a Nucleofector device that that is designed to transfer genes for primary cell research where non-viral gene transfer is required.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 02-Jul-2008 | $148M | 000.00 | 00000 | Completed | Product Development |
2. Early Stage VC | 13-Jun-2001 | 000.00 | 000.00 | Completed | Product Development | |
1. Early Stage VC | Completed |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
3i Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Earlybird Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
NRW.Bank | Investment Bank | Minority | 000 0000 | 000000 0 | |
Technologie-Beteiligungs-Gesellschaft | Venture Capital | Minority | 000 0000 | 000000 0 | |
Technomedia Kapitalbeteiligungsgesellschaft Koeln | Venture Capital | Minority | 000 0000 | 000000 0 |